Treatment of renal amyloidosis in rheumatoid arthritis requires further investigation: comment on the case report by Elkayam et al.
Ciboddo
Gianfranco
G
Idone
Cristina
C
D000368:Aged; D017772:Amyloid Neuropathies / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D011507:Proteinuria / Q000188:drug therapy* / Q000209:etiology; D017211:Treatment Failure
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab